Archive for Mesothelioma

Malignant Pleural Mesothelioma: A Silent Killer

Malignant pleural mesothelioma (MPM) is the most typical cancer within the pleura (area encircling the lungs). It is definitely an abnormal as well as steady division of mesothelial cells which encompass a large section of the pleural area. A powerful causal affiliation with asbestos subjection is clearly established. Different presentations of this disorder are also reported, although seldom.

Malignant pleural mesothelioma is an uncommon neoplasm for which the key risk cause is former asbestos exposure. During the past 10 years, there has been progress around the diagnosis, staging as well as biology of mesothelioma. In addition, treatment for this killer is still greatly controversial which enable it to range from supportive (palliative) care by itself up to aggressive multidimensional therapy. Calculating this, potential scientific tests within cautiously staged patients are essential to see what approaches to management could achieve the best survival rate.

At this time, chest tube drainage via a tube positioned within the chest cavity and pleurodesis, “a procedure which brings about the linings around the lung to stay together and prevents the increase of fluid”, is believed to be the most typical of comfort care treatment for malignant pleural Mesothelioma. Fluid build-up, or pleural effusion, is often the first indication of this grave condition which normally causes the patient to seek medical intervention. Once this effusion has taken place, it is usually obstinate and comes back rapidly subsequent to an original thoracentesis (draining of the fluid). In efforts to get rid of this dilemma, the pleural space must be closed by means of a procedure called pleurodesis. This procedure involves using a “talc slurry” or other sclerosing factor which makes the sticking outcome talked about previously.

As stated, malignant pleural Mesothelioma is an aggressive thoracic malignancy affiliated with contact with asbestos, also its incidence is predicted to increase during the first part of this century. Chemotherapy will be mainstay of any aggressive treatment of the disease, nevertheless there does exist ample confirmation to verify that this standard of care has come forth just in the past 5 years. Experimental clinical trials of second-line and distinctive agents are emerging from an improved comprehension from the mesothelioma cell make-up. These tests, together with high-quality translational examination have revealed that many developments possess a real potential to improve the outlook of sufferers at a time of an increasing incidence.

Please do not forget that malignant pleural Mesothelioma will be the most frequently recognized kind of any malignant mesothelioma. That said, numerous factors are used in determining the survival rate because of this aggressive cancer and some are better understood than others. Estimates of average survival times of this population vary from one to 2 years furthermore these averages depend on a variety of underlying criteria including the type and extent of spread belonging to the mesothelioma. Based on recent figures, persons recognized with malignant pleural Mesothelioma, only have a 7 percent survival time to 5 years following diagnosis. However, this outlook is increasingly improving in the midst of some promising investigational management and several will survive well beyond the stated five years from the point of diagnosis.

Of note is the truth that no reports have included formal dealings of quality of life matters when keeping track of the survival rates for this population plus a small number of scientific studies have reported regarding strategies involved to rate symptom control as well. Palliative radiation treatment may offer symptom treatment and increased quality of life (QOL) for these sufferers.

In review, malignant pleural Mesothelioma (MPM) is the most common neoplasm of the pleura (area around the lungs). It entails an irregular proliferation of mesothelial cells that incorporates a large part of the pleural space. A powerful causal connection to asbestos exposure is well proven. It is the most often recognized type of any malignant mesothelioma as well as includes a survival time of approximately 2 years after diagnosis. Nevertheless, breakthroughs in the treatment and control of this debilitating disease can increase survival rate to above five years and in some cases longer. In other terms, there is hope.

Category: Mesothelioma /

Malignant Mesothelioma Diagnosis

The most critical form of mesothelioma is the malignant form. Known as malignant mesothelioma, the primary causal factor is asbestos infection. According to the US National Cancer Institute, “Malignant mesothelioma is a disease in which cancer (malignant) cells are found in the sac lining the chest (the pleura), the lining of the abdominal cavity (the peritoneum) or the lining around the heart (the pericardium).”

Mesothelioma can be classified into three types – pleural mesothelioma, peritoneal mesothelioma and pericardial mesothelioma. Pleural mesothelioma refers to a cancer of the lining of the lung (pleura), peritoneal mesothelioma refers to a cancer of the abdominal cavity (peritoneum) lining, and pericardial mesothelioma is a cancer that occurs in the lining that surrounds the heart (pericardium). The subtypes of mesothelioma are of three basic types, one very aggressive, one least aggressive, and one lying between the two extremes.

Malignant mesothelioma can be diagnosed through several imaging techniques. These imaging techniques enable physicians to assess mesothelioma. Once mesothelioma is suspected, patients are advised to undergo several tests, like X-ray, Computed Tomography (CT) scan, Magnetic Resonance Imaging (MRI) scans, and Positron Emission Tomography (PET) imaging. The physician may also like to undertake special mesothelioma tests like thoracoscopy, peritoneoscopy and biopsy.

Learning about the stage of mesothelioma is a critical factor that helps physicians to decide the treatment plan. If the cancer is confined to the pleura, mesothelioma is considered localized. If the cancer spreads beyond the pleura and to other parts of the body such as the lungs, abdominal cavity, lymph nodes and the chest wall, mesothelioma is considered to be in an advanced stage.

The oft used and the oldest system for determining the stages of mesothelioma is the Butchart System. The Butchart System is based on the extent of the primary tumor mass available in a patient. This system divides mesothelioma into four stages. The TNM system, a slightly advanced system over the Butchart System, determines staging through variables of tumor in mass and the spread, the lymph node involvement and metastasis. However, the latest system is known as the Brigham System, where staging is done as per the respectability and lymph node involvement. In spite of such modern techniques, a definitive diagnosis of mesothelioma still remains possible through fluid diagnosis and tissue biopsy.

Category: Mesothelioma / Tags: , , , , , , ,

Peritoneal Mesothelioma — The Cancer Of Abdominal Lining

One of the fatal types of mesothelioma is Peritoneal Mesothelioma in which the cancerous cells attack the lining of the abdomen called Peritoneum. Peritoneum is the thin membrane, which shields various organs of the abdomen and also provides a lubricating fluid to enable the organs to move and work properly. Peritoneal Mesothelioma, which affects this lining, is yet now a relatively rare disease that accounts for about 1/5 of all mesotheliomas. Its only known cause in the U.S. till date is previous exposure to asbestos.

Major symptoms

Though Mesothelioma is neither age nor sex specific, peritoneal Mesothelioma is mostly seen in men who are in the age group of 50-70 years. There are a number of symptoms of peritoneal mesothelioma most of which start appearing after 20, 30 or 50 years after the exposure to asbestos. These symptoms may include weight loss (however, waist line may increase), pain or swelling in the abdomen, weakness, loss of appetite, bowel obstruction, anemia, nausea and fever. Also, fluid often accumulates in the peritoneal space leading to a condition called Ascites.

Diagnosis of peritoneal mesothelioma

The initial step towards detection of peritoneal mesothelioma includes X-rays and CT scans. For confirmed diagnosis, however the doctor needs to do biopsy whereby a piece of tissue is cut from the affected part of the victim’s body and is placed under microscope for examination. If the disease is detected at an early stage it stands better chance of getting cured than the state of diffuse peritoneal mesothelioma, where the cancer has already spread to various parts.

The cure

It’s true that peritoneal mesothelioma is fatal and leads to several deaths every year. However, with continued researches, several modes of treatments have been embarked upon and in the future there is a fair chance of the disease becoming absolutely curable. The types of treatment of peritoneal mesothelioma include surgery, radiation therapy and chemotherapy.

In surgery a part of the abdominal tissue is cut out to remove the tumor. At times the doctor may also need to remove a lung or a portion of the diaphragm as per the requirement of the surgery. Radiation therapy, the second method, requires the application of high energy X-rays to shrink the tumor and kill the malignant cells. The rays may be applied from an external machine or by placing the radiation source directly to the affected part of the body, by means of plastic tubes. Last treatment type is the chemotherapy whereby a combination of drugs is applied to kill the cancer cells. The drugs may be administered by mouth in the capsule form or may be applied intravenously via needle.

However, it is essential to mention that cost of treating any form of cancer is extravagant and you may consult a mesothelioma lawyer to earn you a handsome compensation from the authority who was responsible for your prior exposure to asbestos.

Category: Mesothelioma / Tags: , , , , , ,
Page 1 of 1712345...10...Last »